SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-11-041727
Filing Date
2011-04-29
Accepted
2011-04-29 13:15:10
Documents
6
Period of Report
2011-06-14
Effectiveness Date
2011-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A f59022dedef14a.htm DEF 14A 658673
2 GRAPHIC f59022def5902202.gif GRAPHIC 1203
3 GRAPHIC f59022def5902200.gif GRAPHIC 1203
4 GRAPHIC f59022def5902201.gif GRAPHIC 1433
5 GRAPHIC f59022def5902203.gif GRAPHIC 115769
6 GRAPHIC f59022def5902204.gif GRAPHIC 91161
  Complete submission text file 0000950123-11-041727.txt   951082
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 11792856
SIC: 2834 Pharmaceutical Preparations